N. Zimmermann

发表

Stakeholder preferences about policy objectives and measures of pharmaceutical pricing and reimbursement

S. Vogler, N. Zimmermann, K. Habimana, 2016 .

Computed tomography for the diagnosis of sinusitis and air sacculitis in orangutans

H. Steinmetz, N. Zimmermann, 2011 .

Upper respiratory tract disease in captive orangutans (Pongo sp.): prevalence in 20 European zoos and predisposing factors

R. Zingg, M. Clauss, H. Steinmetz, 2011, Journal of medical primatology.

The Pharmaceutical Pricing and Reimbursement Information (PPRI) initiative—Experiences from engaging with pharmaceutical policy makers

S. Vogler, N. Zimmermann, C. Leopold, 2014 .

Price comparison of high-cost originator medicines in European countries

Z. Babar, S. Vogler, N. Zimmermann, 2017, Expert review of pharmacoeconomics & outcomes research.

Asthma intervention program prevents readmissions in high healthcare users.

K. Schechtman, M. Castro, N. Zimmermann, 2003, American journal of respiratory and critical care medicine.

Challenges and opportunities for pharmaceutical pricing and reimbursement policies

Z. Babar, S. Vogler, N. Zimmermann, 2015, Journal of Pharmaceutical Policy and Practice.

Species-specific patterns in fecal glucocorticoid and androgen levels in zoo-living orangutans (Pongo spp.).

E. Willems, H. Steinmetz, M. Heistermann, 2011, General and comparative endocrinology.

Policy interventions related to medicines: Survey of measures taken in European countries during 2010-2015.

S. Vogler, N. Zimmermann, K. de Joncheere, 2016, Health policy.

Update on COPD

N. Zimmermann, 2016 .

Policy cooperation and interface issues

Z. Babar, S. Vogler, N. Zimmermann, 2015, Journal of pharmaceutical policy and practice.

Availability and procurement conditions of originator and generic medicines in hospitals - an exploratory study in fi ve medium-sized European countries

S. Vogler, N. Zimmermann, Jan Mazag, 2014 .

Pharmaceutical policies in European countries in response to the global financial crisis

S. Vogler, N. Zimmermann, K. de Joncheere, 2011, Southern med review.

Upper respiratory tract diseases in captive orangutans (Pongo abelii, Pongo pygmaeus): prevalence in 20 European zoos and possible predisposing factors

N. Zimmermann, 2011 .

Fecal Glucocorticoid Measurements and Their Relation to Rearing, Behavior, and Environmental Factors in the Population of Pileated Gibbons (Hylobates pileatus) Held in European Zoos

R. Zingg, M. Clauss, H. Steinmetz, 2011, International Journal of Primatology.

Discounts and rebates granted to public payers for medicines in European countries

A. Bucsics, S. Vogler, N. Zimmermann, 2012, Southern med review.

Tendering for off‐patent outpatient medicines: lessons learned from experiences in Belgium, Denmark and the Netherlands

S. Vogler, N. Zimmermann, M. Gombocz, 2017 .

Preparing Price Studies – Key Methodological Decisions

S. Vogler, N. Zimmermann, P. Schneider, 2019, Medicine Price Surveys, Analyses and Comparisons.

Understanding the components of pharmaceutical expenditure—overview of pharmaceutical policies infl uencing expenditure across European countries

S. Vogler, N. Zimmermann, C. Habl, 2013 .

Send Orders of Reprints at Reprints@benthamscience.net Discounts and Rebates Granted for Medicines for Hospital Use in Five European Countries

S. Vogler, N. Zimmermann, C. Leopold, 2022 .

Evolution of Average European Medicine Prices: Implications for the Methodology of External Price Referencing

S. Vogler, N. Zimmermann, P. Schneider, 2019, PharmacoEconomics - Open.

Pharmaceutical policies in a crisis? Challenges and solutions identified at the PPRI Conference

Z. Babar, S. Vogler, N. Zimmermann, 2016, Journal of pharmaceutical policy and practice.

WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies European price comparison of high-cost hospital medicines

S. Vogler, N. Zimmermann, P. Schneider, 2010 .

Study of the policy mix for the reimbursement of medicinalproducts. Proposal for a best practice-based approachbased on stakeholder assessment

S. Vogler, N. Zimmermann, K. Habimana, 2014 .

The Pharmaceutical Pricing and Reimbursement Information (PPRI) network – a decade of exchange of information and policy research?

S. Vogler, N. Zimmermann, K. de Joncheere, 2015, Journal of pharmaceutical policy and practice.

The role of discounts and loss leaders in medicine procurement in Austrian hospitals - a primary survey of official and actual medicine prices

S. Vogler, N. Zimmermann, C. Habl, 2013, Cost Effectiveness and Resource Allocation.

Computertomographic evaluation of the upper respiratory tract in orang-utans. (Pongo pygmaeus, Pongo abelii)

R. Zingg, H. Steinmetz, J. Hatt, 2009 .

Abstracts from the 4th International PPRI Conference 2019: Medicines access challenge – The value of pricing and reimbursement policies

R. Busse, S. Vogler, N. Zimmermann, 2019, Journal of Pharmaceutical Policy and Practice.

Addressing the medicines access challenge through balance, evidence, collaboration and transparency: key take-away lessons of the 4th PPRI Conference

R. Busse, D. Panteli, Z. Babar, 2021, Journal of pharmaceutical policy and practice.

Policy cooperation and interface issues

Z. Babar, S. Vogler, N. Zimmermann, 2015, Journal of Pharmaceutical Policy and Practice.

The Pharmaceutical Pricing and Reimbursement Information (PPRI) initiative—Experiences from engaging with pharmaceutical policy makers

S. Vogler, N. Zimmermann, C. Leopold, 2014 .

OHP-073 Survey of Interface Management Measures Regarding Medicines

S. Vogler, N. Zimmermann, C. Leopold, 2013 .